Sign in to view content

Two years visual acuity and anatomical outcomes of patients with diabetic macular oedema treated with intravitreal aflibercept in a real life setting

Marko Lukic, MD PhD FEBO FASRS

Video
Published 2019

Related

Adjunctive Focal Laser Following Central Fluid Resolution After Bevacizumab, Ranibizumab, or Aflibercept Injection: A Secondary Analysis of Protocol T
Jennifer R Gallagher, MD
Annual Meeting Talks
2020
Obstructive Sleep Apnea as a Risk Factor for Diabetic Retinopathy Progression and Systemic Complications
Ehsan Rahimy, MD
Annual Meeting Talks
2024
What Happens to Diabetic Retinopathy Severity Scores With Less Aggressive Treatment? A Post Hoc Analysis of the RISE and RIDE Open Label Extension Study
Roger A. Goldberg, MD, MBA
Annual Meeting Talks
2019

Category: Diabetic Retinopathy

See more